LUKE PAIK: Open Payments
NPI 1215698535 · SIMI VALLEY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,207 in 46 payments from 12 companies in 2025. Trend: 2023 $1,281 · 2024 $1,385 · 2025 $1,207
Food & beverage: $1,207
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 20 | $566 |
| AstraZeneca Pharmaceuticals LP | 4 | $101 |
| ABBVIE INC. | 5 | $96 |
| Merck Sharp & Dohme LLC | 3 | $90 |
| Astellas Pharma US Inc | 2 | $58 |
| Amgen Inc. | 2 | $56 |
| Lilly USA, LLC | 2 | $52 |
| GlaxoSmithKline, LLC. | 2 | $50 |
| PFIZER INC. | 2 | $44 |
| Esperion Therapeutics, Inc. | 2 | $38 |
Products named: Ozempic, Rybelsus, Wegovy, CAPVAXIVE, BREZTRI, Veozah, EVENITY, QULIPTA.
Industry payments across CA — which companies pay providers there.
